Annual Total Expenses
$3.24 B
+$89.52 M+2.84%
31 December 2023
Summary:
Jazz Pharmaceuticals annual total expenses is currently $3.24 billion, with the most recent change of +$89.52 million (+2.84%) on 31 December 2023. During the last 3 years, it has risen by +$1.64 billion (+102.53%). JAZZ annual total expenses is now at all-time high.JAZZ Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Expenses
$794.76 M
-$29.62 M-3.59%
30 September 2024
Summary:
Jazz Pharmaceuticals quarterly total expenses is currently $794.76 million, with the most recent change of -$29.62 million (-3.59%) on 30 September 2024. Over the past year, it has dropped by -$4.99 million (-0.62%). JAZZ quarterly total expenses is now -8.80% below its all-time high of $871.44 million, reached on 31 December 2023.JAZZ Quarterly Total Expenses Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JAZZ Total Expenses Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +2.8% | -0.6% |
| 3 y3 years | +102.5% | -1.9% |
| 5 y5 years | +162.5% | +125.3% |
JAZZ Total Expenses High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +102.5% | -8.8% | +9.4% |
| 5 y | 5 years | at high | +162.5% | -8.8% | +125.3% |
| alltime | all time | at high | +4018.6% | -8.8% | +2857.3% |
Jazz Pharmaceuticals Total Expenses History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $794.76 M(-3.6%) |
| June 2024 | - | $824.38 M(-0.2%) |
| Mar 2024 | - | $825.78 M(-5.2%) |
| Dec 2023 | $3.24 B(+2.8%) | $871.44 M(+9.0%) |
| Sept 2023 | - | $799.75 M(+0.0%) |
| June 2023 | - | $799.68 M(+4.4%) |
| Mar 2023 | - | $765.76 M(-11.0%) |
| Dec 2022 | $3.15 B(+7.6%) | $860.51 M(+10.0%) |
| Sept 2022 | - | $782.24 M(+0.5%) |
| June 2022 | - | $778.18 M(+7.2%) |
| Mar 2022 | - | $726.17 M(-14.3%) |
| Dec 2021 | $2.92 B(+83.0%) | $847.35 M(+4.6%) |
| Sept 2021 | - | $809.75 M(-1.4%) |
| June 2021 | - | $821.40 M(+84.4%) |
| Mar 2021 | - | $445.46 M(-2.3%) |
| Dec 2020 | $1.60 B(+5.2%) | $456.10 M(+15.6%) |
| Sept 2020 | - | $394.68 M(+9.2%) |
| June 2020 | - | $361.31 M(-6.4%) |
| Mar 2020 | - | $386.01 M(-25.8%) |
| Dec 2019 | $1.52 B(+23.2%) | $520.50 M(+47.5%) |
| Sept 2019 | - | $352.82 M(+7.7%) |
| June 2019 | - | $327.65 M(+2.9%) |
| Mar 2019 | - | $318.44 M(+9.3%) |
| Dec 2018 | $1.23 B(+22.7%) | $291.40 M(+3.9%) |
| Sept 2018 | - | $280.60 M(-7.8%) |
| June 2018 | - | $304.38 M(-14.7%) |
| Mar 2018 | - | $356.81 M(+24.2%) |
| Dec 2017 | $1.00 B(+15.2%) | $287.19 M(+14.7%) |
| Sept 2017 | - | $250.40 M(+10.1%) |
| June 2017 | - | $227.34 M(-5.2%) |
| Mar 2017 | - | $239.91 M(+3.8%) |
| Dec 2016 | $872.57 M(+11.1%) | $231.12 M(+3.7%) |
| Sept 2016 | - | $222.93 M(+4.9%) |
| June 2016 | - | $212.43 M(+3.1%) |
| Mar 2016 | - | $206.10 M(+1.7%) |
| Dec 2015 | $785.06 M | $202.73 M(-3.2%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2015 | - | $209.34 M(+16.0%) |
| June 2015 | - | $180.45 M(-6.3%) |
| Mar 2015 | - | $192.54 M(+0.8%) |
| Dec 2014 | $735.30 M(+39.5%) | $191.04 M(+10.1%) |
| Sept 2014 | - | $173.55 M(-5.7%) |
| June 2014 | - | $184.13 M(-1.3%) |
| Mar 2014 | - | $186.58 M(+32.1%) |
| Dec 2013 | $527.12 M(+35.8%) | $141.28 M(+8.2%) |
| Sept 2013 | - | $130.61 M(-0.4%) |
| June 2013 | - | $131.19 M(+5.8%) |
| Mar 2013 | - | $124.05 M(+6.6%) |
| Dec 2012 | $388.13 M(+168.7%) | $116.32 M(-3.2%) |
| Sept 2012 | - | $120.22 M(+41.8%) |
| June 2012 | - | $84.80 M(+27.0%) |
| Mar 2012 | - | $66.79 M(+45.6%) |
| Dec 2011 | $144.45 M(+24.5%) | $45.87 M(+15.9%) |
| Sept 2011 | - | $39.59 M(+28.9%) |
| June 2011 | - | $30.71 M(+8.6%) |
| Mar 2011 | - | $28.28 M(+1.6%) |
| Dec 2010 | $115.99 M(+3.1%) | $27.83 M(-8.2%) |
| Sept 2010 | - | $30.31 M(+1.4%) |
| June 2010 | - | $29.90 M(+7.0%) |
| Mar 2010 | - | $27.94 M(+4.0%) |
| Dec 2009 | $112.52 M(-45.9%) | $26.87 M(-0.8%) |
| Sept 2009 | - | $27.10 M(-7.3%) |
| June 2009 | - | $29.25 M(-0.2%) |
| Mar 2009 | - | $29.30 M(-29.5%) |
| Dec 2008 | $208.12 M(+2.0%) | $41.55 M(-8.7%) |
| Sept 2008 | - | $45.49 M(-27.4%) |
| June 2008 | - | $62.63 M(+7.2%) |
| Mar 2008 | - | $58.44 M(-21.3%) |
| Dec 2007 | $204.08 M(+66.0%) | $74.22 M(+89.0%) |
| Sept 2007 | - | $39.27 M(-31.1%) |
| June 2007 | - | $57.02 M(+69.8%) |
| Mar 2007 | - | $33.57 M |
| Dec 2006 | $122.91 M(+56.4%) | - |
| Dec 2005 | $78.59 M | - |
FAQ
- What is Jazz Pharmaceuticals annual total expenses?
- What is the all time high annual total expenses for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals annual total expenses year-on-year change?
- What is Jazz Pharmaceuticals quarterly total expenses?
- What is the all time high quarterly total expenses for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly total expenses year-on-year change?
What is Jazz Pharmaceuticals annual total expenses?
The current annual total expenses of JAZZ is $3.24 B
What is the all time high annual total expenses for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high annual total expenses is $3.24 B
What is Jazz Pharmaceuticals annual total expenses year-on-year change?
Over the past year, JAZZ annual total expenses has changed by +$89.52 M (+2.84%)
What is Jazz Pharmaceuticals quarterly total expenses?
The current quarterly total expenses of JAZZ is $794.76 M
What is the all time high quarterly total expenses for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high quarterly total expenses is $871.44 M
What is Jazz Pharmaceuticals quarterly total expenses year-on-year change?
Over the past year, JAZZ quarterly total expenses has changed by -$4.99 M (-0.62%)